BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25964571)

  • 21. Development and external validation of a prostate health index-based nomogram for predicting prostate cancer.
    Zhu Y; Han CT; Zhang GM; Liu F; Ding Q; Xu JF; Vidal AC; Freedland SJ; Ng CF; Ye DW
    Sci Rep; 2015 Oct; 5():15341. PubMed ID: 26471350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
    Graefen M; Augustin H; Karakiewicz PI; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino PT; Kattan MW; Huland H
    Urologe A; 2003 May; 42(5):685-92. PubMed ID: 12750804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.
    Imamoto T; Suzuki H; Utsumi T; Takano M; Suyama T; Kawamura K; Kamiya N; Naya Y; Ueda T; Ichikawa T
    Urology; 2010 Aug; 76(2):404-10. PubMed ID: 19716590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction.
    Oliveira M; Marques V; Carvalho AP; Santos A
    BJU Int; 2011 Jun; 107(11):1780-3. PubMed ID: 20883487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
    Wang Y; Xie S; Shangguan X; Pan J; Zhu Y; Xin Z; Xu F; Shao X; Fan L; Sha J; Liu Q; Dong B; Xue W
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1157-1166. PubMed ID: 28283782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
    Walz J; Graefen M; Chun FK; Erbersdobler A; Haese A; Steuber T; Schlomm T; Huland H; Karakiewicz PI
    Eur Urol; 2006 Sep; 50(3):498-505. PubMed ID: 16631303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens.
    Satake N; Ohori M; Yu C; Kattan MW; Ohno Y; Miyakawa A; Hatano T; Tachibana M
    Int J Urol; 2010 Mar; 17(3):267-72. PubMed ID: 20132361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
    Wang SY; Cowan JE; Cary KC; Chan JM; Carroll PR; Cooperberg MR
    BJU Int; 2014 Dec; 114(6b):E18-E24. PubMed ID: 24712895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA.
    Kara O; Elshafei A; Nyame YA; Akdogan B; Malkoc E; Gao T; Altan M; Citamak B; Mammadov E; Dursun F; Greene DJ; Senkul T; Ates F; Ozen H; Stephen Jones J
    Int Urol Nephrol; 2016 Oct; 48(10):1623-9. PubMed ID: 27236298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
    Chun FK; Steuber T; Erbersdobler A; Currlin E; Walz J; Schlomm T; Haese A; Heinzer H; McCormack M; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2006 May; 49(5):820-6. PubMed ID: 16439050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
    Moussa AS; Kattan MW; Berglund R; Yu C; Fareed K; Jones JS
    BJU Int; 2010 Feb; 105(3):352-8. PubMed ID: 19681898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
    Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
    Svatek R; Karakiewicz PI; Shulman M; Karam J; Perrotte P; Benaim E
    Eur Urol; 2006 Apr; 49(4):666-74. PubMed ID: 16423446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K
    Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel nomogram to predict the probability of prostate cancer on repeat biopsy.
    Benecchi L; Pieri AM; Melissari M; Potenzoni M; Pastizzaro CD
    J Urol; 2008 Jul; 180(1):146-9. PubMed ID: 18485383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
    Chun FK; Briganti A; Shariat SF; Graefen M; Montorsi F; Erbersdobler A; Steuber T; Salonia A; Currlin E; Scattoni V; Friedrich MG; Schlomm T; Haese A; Michl U; Colombo R; Heinzer H; Valiquette L; Rigatti P; Roehrborn CG; Huland H; Karakiewicz PI
    BJU Int; 2006 Aug; 98(2):329-34. PubMed ID: 16879673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy.
    Wu Q; Li F; Yin X; Gao J; Zhang X
    Medicine (Baltimore); 2021 Dec; 100(50):e28196. PubMed ID: 34918677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
    Briganti A; Gallina A; Suardi N; Chun FK; Walz J; Heuer R; Salonia A; Haese A; Perrotte P; Valiquette L; Graefen M; Rigatti P; Montorsi F; Huland H; Karakiewicz PI
    BJU Int; 2008 Mar; 101(5):556-60. PubMed ID: 18005204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.